•

Drug donanemab seen as turning point in dementia fight

https://www.bbc.com/news/health-66221116?at_ptr_name=twitter&at_link_type=web_link&at_campaign_type=owned&at_format=link&at_link_origin=BBCBreaking&at_campaign=Social_Flow&at_medium=social&at_bbc_team=editorial&at_link_id=15C91B3A-24AD-11EE-9433-62BAFF7C7F44

The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.

Drug donanemab seen as turning point in dementia fight

The antibody treatment donanemab slows clinical decline by around a third, a large trial confirms.

5 comments

BoCanCan

•

It delays dementia by 4-7 months, and also causes bleeding and swelling in the brain which killed 3 out of 1,700 participants in the study.

It’s better than nothing I guess but it’s not a particularly good treatment.

OptimisticPrime

•

Sure, but treatments of something that complex has to start somewhere. It seems to go in the right direction and upcoming treatments may build on that. I am not sure that anyone could have expected after many failures to just find the magical cure that completely cures Alzheimers.

FaceDeer

•

The results regarding amyloid plaques just keep going back and forth over time, I'm very curious how this will ultimately play out. I suppose even if the plaques are a symptom rather than the underlying cause it can still be helpful clearing them away.

claustrum

•

For anyone interested in neuroscience, https://kbin.social/m/neuro was just launched :)

dedale

•

A side effect of covid is that we now accept treatments that don't quite work.